Concepedia

Julie Janes

JJ

Statistics

Publications

14

Citations

2.2K

H-Index

12

Active since

2005

Affiliations

Calithera (United States)(Current)

University of California San Diego

Amgen (United States)

Julie Janes is an author at Calithera (United States) specializing in medicine, immunology, and cancer research.

Top concepts

Publications per year

2005–2017

14

Publications

14

Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer

Matt I. Gross, Susan D. Demo, Jennifer B. Dennison et al. · Molecular Cancer Therapeutics · 2014 · 1K citations

, , +18

Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment

Susanne Steggerda, Mark K. Bennett, Jason Chen et al. · Journal for ImmunoTherapy of Cancer · 2017 · 416 citations · Full text

Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer

Milica Momcilovic, Sean T. Bailey, Jason T. Lee et al. · Cell Reports · 2017 · 162 citations · Full text

Cytokine regulation of MMP-9 in peripheral glia: Implications for pathological processes and pain in injured nerve

Sharmila Chattopadhyay, Robert R. Myers, Julie Janes et al. · Brain Behavior and Immunity · 2007 · 141 citations · Full text

, , +12

Pharmacology of AMG 416 (Velcalcetide), a Novel Peptide Agonist of the Calcium-Sensing Receptor, for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients

Sarah Walter, Amos Baruch, Jin Dong et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 111 citations

1–5 of 14